302 related articles for article (PubMed ID: 11036132)
1. Factors influencing survival after resection for periampullary neoplasms.
Bouvet M; Gamagami RA; Gilpin EA; Romeo O; Sasson A; Easter DW; Moossa AR
Am J Surg; 2000 Jul; 180(1):13-7. PubMed ID: 11036132
[TBL] [Abstract][Full Text] [Related]
2. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
[TBL] [Abstract][Full Text] [Related]
3. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
4. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
5. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.
Yeo CJ; Cameron JL; Sohn TA; Lillemoe KD; Pitt HA; Talamini MA; Hruban RH; Ord SE; Sauter PK; Coleman J; Zahurak ML; Grochow LB; Abrams RA
Ann Surg; 1997 Sep; 226(3):248-57; discussion 257-60. PubMed ID: 9339931
[TBL] [Abstract][Full Text] [Related]
6. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s.
Sohn TA; Lillemoe KD; Cameron JL; Huang JJ; Pitt HA; Yeo CJ
J Am Coll Surg; 1999 Jun; 188(6):658-66; discussion 666-9. PubMed ID: 10359359
[TBL] [Abstract][Full Text] [Related]
7. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
8. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
9. Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome.
Sohn TA; Lillemoe KD; Cameron JL; Pitt HA; Huang JJ; Hruban RH; Yeo CJ
Ann Surg; 1999 Mar; 229(3):393-400. PubMed ID: 10077052
[TBL] [Abstract][Full Text] [Related]
10. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
11. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
13. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
[TBL] [Abstract][Full Text] [Related]
14. Surgical experience with pancreatic and periampullary cancer.
Herter FP; Cooperman AM; Ahlborn TN; Antinori C
Ann Surg; 1982 Mar; 195(3):274-81. PubMed ID: 6277259
[TBL] [Abstract][Full Text] [Related]
15. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
Schwarz RE; Keny H
Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
17. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
18. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
[TBL] [Abstract][Full Text] [Related]
19. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
[TBL] [Abstract][Full Text] [Related]
20. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]